4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-20-080841
Options or other derivatives
- VP, Chief Medical Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Friend John E. II VP, Chief Medical Officer | 2020-07-01 | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/tm2023996d2_4.xml…